Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Uterine Cervical Neoplasms 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Heart Diseases 1 Endometrial Neoplasms 1 Disease 1 Atrial Fibrillation 1 Arrhythmias, Cardiac 1

Interventions

Mammography 4 Magnetic Resonance Spectroscopy 3 pembrolizumab 1 Vertical Dimension 1 Therapeutics 1 TKM-080301 1 Surveys and Questionnaires 1 Sensitivity Training Groups 1 Self-Management 1 Referral and Consultation 1 Quality of Life 1 Professional Autonomy 1 Patient Positioning 1 Paclitaxel 1 Methylene Blue 1 Mass Screening 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Interleukin-15 1 Gemcitabine 1 Exercise 1 Drug Delivery Systems 1 Doxorubicin 1 Counseling 1 Blood Specimen Collection 1 Biopsy 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Mass Screening × Breast × Clear all

NCT04590560 2024-12-09

MISS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Recruiting

60,000 enrolled

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡